HIV-1 evolution following transmission to an HLA-B*5801-positive patient

Journal of Infectious Diseases

Volumn 200, Issue 12, 2009, Pages 1820-1824

  O'Connell, Karen A ^a   Xu, Jie ^a   Durbin, Anna P ^b   Apuzzo, Linda G ^c   Imteyaz, Hejab ^c   Williams, Thomas M ^e   Ray, Stuart C ^a   Margolick, Joseph B ^c   Siliciano, Robert F ^a,d   Blankson, Joel N ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^e UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAG PROTEIN; HLA B ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEF PROTEIN; POL PROTEIN;

ADULT; ALLELE; ARTICLE; CASE REPORT; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSPOT ASSAY; EVOLUTION; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; T LYMPHOCYTE; VIRUS GENOME; VIRUS LOAD; VIRUS MUTATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

ADULT; EPITOPES; EVOLUTION, MOLECULAR; FEMALE; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENOME, VIRAL; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HLA-B ANTIGENS; HUMANS; IMMUNOBLOTTING; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MUTATION, MISSENSE; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; POL GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; VIRAL LOAD;

EID: 71949099660     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/648377     Document Type: Article

References (15)

1. 1. Kiepiela P, Leslie AJ, Honeyborne I, et al. Dominant influence of HLAB in mediating the potential co-evolution of HIV and HLA. Nature 2004; 432:769-775 (Pubitemid 39656298)
2. Migueles SA, Sabbaghian MS, Shupert WL, et al. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIVinfected long term nonprogressors. Proc Natl Acad Sci U S A 2000; 97:2709-2714
3. 3. Lazaryan A, Lobashevsky E, Mulenga J, et al. Human leukocyte antigen B58 supertype and human immunodeficiency virus type 1 infection in native Africans. J Virol 2006; 80:6056-6060 (Pubitemid 43849183)
4. + long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral Gag sequences. J Virol 2003; 77:6889-6898
5. + elite suppressors despite CTL escape mutations. J Exp Med 2006; 203:1357-1369
6. Miura T, Brockman MA, Schneidewind A, et al. HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare Gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphotye recognition. J Virol 2009; 83:2743-2755
7. 7. Leslie AJ, Pfafferott KJ, Chetty P, et al. HIV evolution: CTL escape mutation and reversion after transmission. Nat Med 2004; 10:282-289 (Pubitemid 38667619)
8. 8. Leslie A, Kavanagh D, Honeyborne I, et al. Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA. J Exp Med 2005; 201:891-902. (Pubitemid 40524459)
9. Crawford H, Lumm W, Leslie A, et al. Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients. J Exp Med 2009;206:909-921
10. Brumme ZL, Brumme CJ, Carlson J, et al. Marked epitope- and allelespecific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection. J Virol 2008; 82:9216-9227
11. + T cell frequencies. J Infect Dis 2004; 190:713-721
12. + cytotoxic T lymphocyte response. J Exp Med 2004; 200:1243-1256
13. Goonetilleke N, Liu MK, Salazar-Gonzalez JF, et al. The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J Exp Med 2009; 206:1253-1272
14. Ngumbela KC, Day CL, Mncube Z, et al. Targeting of a CD8 T cell Env epitope presented by HLA-B*5802 is associated with markers of HIV disease progression and lack of selection pressure. AIDS Res Hum Retroviruses 2008; 24:72-82.
15. 15. Altfeld M, Addo MM, Rosenberg ES, et al. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection. AIDS 2003; 17:2581-2591 (Pubitemid 38402336)